letter Open AccessTop 1% cited
Convalescent plasma as a potential therapy for COVID-19
The Lancet Infectious Diseases · 2020 · Vol. 20(4) · pp. 398–400
Long Chen(China International Science and Technology Cooperation)Jing Xiong(Chongqing Medical University)Lei Bao(China International Science and Technology Cooperation)Yuan Shi✉(Chongqing Medical University)
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Impact on ReproductionMedicineConvalescent plasmaExtracorporeal membrane oxygenationCoronavirusMethylprednisolonePneumoniaCoronavirus disease 2019 (COVID-19)OutbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Disease
MeSH terms
BetacoronavirusCOVID-19SARS-CoV-2COVID-19 SerotherapyHumansImmunization, PassiveImmunoglobulinsPneumonia, ViralCoronavirus InfectionsPandemics
Funding
- Chongqing Medical University
Citations
1,086
FWCI
27.12
field-weighted impact
References
12
Percentile
100%
vs. same field & year
Citations per year
Cited by
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Frontiers in Immunology · 2020 · 750 citations
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Clinica Chimica Acta · 2020 · 1,046 citations
Repurposed drugs and their progression against COVID-19
The Pharma Innovation · 2021 · 0 citations
References
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
The Journal of Infectious Diseases · 2014 · 1,038 citations
First Case of 2019 Novel Coronavirus in the United States
New England Journal of Medicine · 2020 · 6,361 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.